{"disease":{"id":"cancer-of-the-pancreas","name":"cancer of the pancreas"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04596865","title":"Recurrence After Whipple's (RAW) Study","phase":"","overall_status":"COMPLETED","enrollment_count":1484,"lead_sponsor_name":"University Hospital Plymouth NHS Trust","has_results":false},{"nct_id":"NCT01231347","title":"QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":800,"lead_sponsor_name":"NantCell, Inc.","has_results":true},{"nct_id":"NCT06947395","title":"Clinical Validation of a Blood Biomarker Test to Detect Early-Stage Pancreatic Cancer (VERIFI)","phase":"","overall_status":"COMPLETED","enrollment_count":386,"lead_sponsor_name":"Immunovia, Inc.","has_results":false},{"nct_id":"NCT04429542","title":"Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":292,"lead_sponsor_name":"Bicara Therapeutics","has_results":false},{"nct_id":"NCT03821025","title":"Self-expandable Metal Stents Versus Multiple Plastic Stents for Palliation of Biliary Obstruction","phase":"NA","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"University of Cape Town","has_results":false},{"nct_id":"NCT05086692","title":"A Beta-only IL-2 ImmunoTherapY Study","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":115,"lead_sponsor_name":"Medicenna Therapeutics, Inc.","has_results":false},{"nct_id":"NCT04789486","title":"Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Dana-Farber Cancer Institute","has_results":false},{"nct_id":"NCT07072728","title":"Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":87,"lead_sponsor_name":"Psyence Australia Pty Ltd","has_results":false},{"nct_id":"NCT05252390","title":"NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":82,"lead_sponsor_name":"Nuvation Bio Inc.","has_results":false},{"nct_id":"NCT02311361","title":"Immune Checkpoint Inhibition (Tremelimumab and/or MEDI4736) in Combination With Radiation Therapy in Patients With Unresectable Pancreatic Cancer","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":65,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT05975593","title":"MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial","phase":"NA","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT03323944","title":"CAR T Cell Immunotherapy for Pancreatic Cancer","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":54,"lead_sponsor_name":"University of Pennsylvania","has_results":false},{"nct_id":"NCT06648434","title":"MK2 Inhibitor in Combination With mFOLFIRINOX for Untreated Metastatic Pancreatic Ductal Adenocarcinoma","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":51,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT05419479","title":"Switch Maintenance in Pancreatic","phase":"PHASE1, PHASE2","overall_status":"SUSPENDED","enrollment_count":46,"lead_sponsor_name":"James Cleary, MD, PhD","has_results":false},{"nct_id":"NCT04331041","title":"Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas Adenocarcinoma","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":42,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT02905578","title":"A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Joseph J. Cullen","has_results":false},{"nct_id":"NCT02830620","title":"Study at the Man of the Profile of Chimiokines in the Anorexia Bound to the Cancerous Cachexy","phase":"NA","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Centre Hospitalier Universitaire de Nice","has_results":false},{"nct_id":"NCT07126158","title":"Stereotactic Body Radiotherapy Plus FAK and RAF/MEK Inhibition in Advanced Pancreatic Adenocarcinoma","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":36,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT03328065","title":"Viewpoints on the Social Representations and Rationale Concerning the Choices of Patients, Doctors and Caregivers With Regard to the Management of Patients With Non-resectable Metastatic Cancer of the Colon, Stomach, Bile Ducts, Rectum, Pancreas or Lung, or Gastrointestinal Neuroendocrine Tumours","phase":"","overall_status":"TERMINATED","enrollment_count":36,"lead_sponsor_name":"Centre Hospitalier Universitaire Dijon","has_results":false},{"nct_id":"NCT05111353","title":"Neoantigen Vaccines in Pancreatic Cancer in the Window Prior to Surgery","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT05043532","title":"Randomized Trial for Optimal Number of Passes Required for Molecular Profiling During EUS-FNB of Pancreatic Cancer","phase":"NA","overall_status":"UNKNOWN","enrollment_count":33,"lead_sponsor_name":"Orlando Health, Inc.","has_results":false},{"nct_id":"NCT02681796","title":"Epidural Analgesia Use in Pancreatic Resections","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":23,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT03883919","title":"Liposomal Irinotecan Plus 5-FU / LV Combined With Paricalcitol in Patients With Advanced Pancreatic Cancer Progressed on Gemcitabine-based Therapy","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT02608229","title":"BVD-523 Plus Nab-paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Cancer","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":18,"lead_sponsor_name":"Washington University School of Medicine","has_results":true},{"nct_id":"NCT02352831","title":"Tosedostat With Capecitabine in Patients With Metastatic Pancreatic Adenocarcinoma","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":16,"lead_sponsor_name":"Washington University School of Medicine","has_results":true},{"nct_id":"NCT04536077","title":"Immunologic Effects of CDX-301 and CDX-1140 in Resectable Pancreatic Cancer Patients","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":16,"lead_sponsor_name":"Washington University School of Medicine","has_results":true},{"nct_id":"NCT03122106","title":"Neoantigen DNA Vaccine in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":15,"lead_sponsor_name":"Washington University School of Medicine","has_results":true},{"nct_id":"NCT04542291","title":"Targeting Pancreatic Cancer With Sodium Glucose Transporter 2 (SGLT2) Inhibition","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Washington University School of Medicine","has_results":true},{"nct_id":"NCT03956056","title":"Neoantigen Peptide Vaccine Strategy in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":12,"lead_sponsor_name":"Washington University School of Medicine","has_results":true},{"nct_id":"NCT04141995","title":"FOLFIRINOX With Digoxin in Patients With Resectable Pancreatic Cancer","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":11,"lead_sponsor_name":"University of Nebraska","has_results":false},{"nct_id":"NCT02950025","title":"Daily Online Adaptation Versus Localization for MRI-Guided SBRT for Unresectable Primary or Oligometastatic Abdominal Malignancies","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":5,"lead_sponsor_name":"Washington University School of Medicine","has_results":true},{"nct_id":"NCT02669914","title":"MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":4,"lead_sponsor_name":"Washington University School of Medicine","has_results":true},{"nct_id":"NCT04123574","title":"A Pilot Study of BXCL701 in Patients With Pancreatic Cancer","phase":"EARLY_PHASE1","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"BioXcel Therapeutics Inc","has_results":false}],"total":33},"guidelines":[],"source":"Drug Landscape verified database"}